Assembly Biosciences
Nasdaq ASMB · South San Francisco, CA
Works in GI & liver · Infectious disease · Renal & urogenital · Women's health
Assembly Biosciences is a clinical trial sponsor based in South San Francisco, CA, listed as Nasdaq ASMB. It has 2 active clinical trials with 100 planned participants, in GI & liver, Infectious disease, Renal & urogenital and Women's health. Since 2021 it has completed 11 trials and stopped 6 early.
Trial track record · since 2021
Financials · Nasdaq ASMB
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Assembly Biosciences
Assembly Biosciences is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 100 planned participants, in GI & liver, Infectious disease, Renal & urogenital, Women's health. Since 2021 it has completed 11 trials and stopped 6 early.
Assembly Biosciences is based in South San Francisco, CA and is listed as Nasdaq ASMB. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Assembly Biosciences; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Assembly Biosciences. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.